# ACS Dobfar S.p.A. – FDA Inspection, Jun 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/76584a80-7e4c-4d59-89b9-7be4a0e1a2f2
Source feed: FDA_Inspections

> FDA inspection 1056132 of ACS Dobfar S.p.A., June 19, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056132
- Company Name: ACS Dobfar S.p.A.
- Inspection Date: 2018-06-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1273719 - 2023-10-27
- FDA Inspection 1122752 - 2019-04-19
- FDA Inspection 973195 - 2016-05-20
- [FDA Inspection 873439 - 2014-03-18](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/11090c73-abed-4fd3-88e5-2aa3e0451cee)
- FDA Inspection 751609 - 2011-07-08

## Related Officers

- [Company Rep](https://www.keypedia.com/people/katie-l-penno/9d71844c-f3d9-4901-ac1f-18eb8de1b9c1)
- [Issuing Officer](https://www.keypedia.com/people/rachael-a-moss/520fef7c-dc4b-47af-9c52-3718ab3fb612)

Company: https://www.keypedia.com/companies/acs-dobfar-spa/73fe0e28-666a-43d8-b163-8ddb7b3542cf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c